SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,868.58 |
| Enterprise Value ($M) | 2,187.01 |
| Book Value ($M) | 765.24 |
| Book Value / Share | 4.57 |
| Price / Book | 3.75 |
| NCAV ($M) | 503.81 |
| NCAV / Share | 3.01 |
| Price / NCAV | 5.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.28 |
| Return on Assets (ROA) | 0.27 |
| Return on Equity (ROE) | 0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.80 |
| Current Ratio | 2.88 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 870.94 |
| Assets | 1,132.36 |
| Liabilities | 367.13 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 957.80 |
| Operating Income | 84.28 |
| Net Income | 226.45 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 157.72 |
| Cash from Investing | -30.54 |
| Cash from Financing | 6.84 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rtw Investments, Lp | 5.20 | -36.49 | |
| 13G/A | BlackRock, Inc. | 11.90 | 74.23 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 308,914 | 1,478,476 | 20.89 | |
| 231,140 | 1,016,922 | 22.73 | |
| 409,800 | 2,008,675 | 20.40 | |
| 816,656 | 2,476,295 | 32.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ABUS – Arbutus Biopharma Corporation | ACLX – Arcellx, Inc. |
| ACRS – Aclaris Therapeutics, Inc. |